Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Menoctone Resistance in Malaria Parasites Is Conferred by M133I Mutations in Cytochrome b That Are Transmissible through Mosquitoes.

Blake LD, Johnson ME, Siegel SV, McQueen A, Iyamu ID, Shaikh AK, Shultis MW, Manetsch R, Kyle DE.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00689-17. doi: 10.1128/AAC.00689-17. Print 2017 Aug.

PMID:
28584157
2.

Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine.

Nuralitha S, Siregar JE, Syafruddin D, Roelands J, Verhoef J, Hoepelman AI, Marzuki S.

Antimicrob Agents Chemother. 2015 Oct 26;60(1):258-63. doi: 10.1128/AAC.00538-15.

3.

Molecular characterization of the cytochrome b gene and in vitro atovaquone susceptibility of Plasmodium falciparum isolates from Kenya.

Ingasia LA, Akala HM, Imbuga MO, Opot BH, Eyase FL, Johnson JD, Bulimo WD, Kamau E.

Antimicrob Agents Chemother. 2015 Mar;59(3):1818-21. doi: 10.1128/AAC.03956-14. Epub 2015 Jan 12.

4.

Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene.

Afonso A, Neto Z, Castro H, Lopes D, Alves AC, Tomás AM, Rosário VD.

Malar J. 2010 May 21;9:135. doi: 10.1186/1475-2875-9-135.

5.

Distinction of Plasmodium falciparum recrudescence and re-infection by MSP2 genotyping: a caution about unstandardized classification criteria.

Rouse P, Mkulama MA, Thuma PE, Mharakurwa S.

Malar J. 2008 Sep 23;7:185. doi: 10.1186/1475-2875-7-185.

6.

First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in Comoros.

Savini H, Bogreau H, Bertaux L, Bouchiba H, Kraemer P, Parzy D, Garnotel E, Rogier C, Simon F, Pradines B.

Antimicrob Agents Chemother. 2008 Jun;52(6):2283-4. doi: 10.1128/AAC.00282-08. Epub 2008 Apr 14. No abstract available.

7.

Plasmodium falciparum malaria and atovaquone-proguanil treatment failure.

Durand R, Prendki V, Cailhol J, Hubert V, Ralaimazava P, Massias L, Bouchaud O, Le Bras J.

Emerg Infect Dis. 2008 Feb;14(2):320-2. doi: 10.3201/eid1402.070945.

8.
9.

Sequence analysis of Plasmodium falciparum cytochrome b in multiple geographic sites.

Ekala MT, Khim N, Legrand E, Randrianarivelojosia M, Jambou R, Fandeur T, Menard D, Assi SB, Henry MC, Rogier C, Bouchier C, Mercereau-Puijalon O.

Malar J. 2007 Dec 17;6:164.

10.

Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.

Happi CT, Gbotosho GO, Folarin OA, Milner D, Sarr O, Sowunmi A, Kyle DE, Milhous WK, Wirth DF, Oduola AM.

Malar J. 2006 Oct 4;5:82.

11.

Association of house spraying with suppressed levels of drug resistance in Zimbabwe.

Mharakurwa S, Mutambu SL, Mudyiradima R, Chimbadzwa T, Chandiwana SK, Day KP.

Malar J. 2004 Oct 18;3:35.

Supplemental Content

Support Center